Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-22 Tax Withholding |
2025-02-25 9:11 pm |
N/A N/A |
ImmunityBio Inc. | IBRX | LAUER REGAN J Chief Accounting Officer |
1,669 | $3.42 | 118,388 (Direct) |
View |
| 2025-02-22 Exercise |
2025-02-25 9:11 pm |
N/A N/A |
ImmunityBio Inc. | IBRX | LAUER REGAN J Chief Accounting Officer |
4,065 | $0 | 118,388 (Direct) |
View |
| 2025-02-22 Tax Withholding |
2025-02-25 9:11 pm |
N/A N/A |
ImmunityBio Inc. | IBRX | SOON-SHIONG PATRICK CALIFORNIA CAPITAL EQUITY LLC MP 13 Ventures LLC Cambridge Equities LP Nant Capital LLC See remarks 10% Owner |
42,071 | $3.42 | 650,022,677 (Direct) |
View |
| 2025-02-22 Exercise |
2025-02-25 9:11 pm |
N/A N/A |
ImmunityBio Inc. | IBRX | SOON-SHIONG PATRICK CALIFORNIA CAPITAL EQUITY LLC MP 13 Ventures LLC Cambridge Equities LP Nant Capital LLC See remarks 10% Owner |
114,329 | $0 | 650,022,677 (Direct) |
View |
| 2025-02-22 Tax Withholding |
2025-02-25 9:11 pm |
N/A N/A |
ImmunityBio Inc. | IBRX | Sachs David C. Chief Financial Officer |
15,860 | $3.42 | 306,921 (Direct) |
View |
| 2025-02-22 Exercise |
2025-02-25 9:11 pm |
N/A N/A |
ImmunityBio Inc. | IBRX | Sachs David C. Chief Financial Officer |
40,650 | $0 | 306,921 (Direct) |
View |
| 2025-02-22 Tax Withholding |
2025-02-25 9:11 pm |
N/A N/A |
ImmunityBio Inc. | IBRX | Adcock Richard CEO & President |
78,167 | $3.42 | 639,296 (Direct) |
View |
| 2025-02-22 Exercise |
2025-02-25 9:11 pm |
N/A N/A |
ImmunityBio Inc. | IBRX | Adcock Richard CEO & President |
152,439 | $0 | 639,296 (Direct) |
View |
| 2025-02-22 Tax Withholding |
2025-02-25 9:11 pm |
N/A N/A |
ImmunityBio Inc. | IBRX | Simon Barry J. Director |
5,453 | $3.42 | 3,274,059 (Direct) |
View |
| 2025-02-22 Exercise |
2025-02-25 9:11 pm |
N/A N/A |
ImmunityBio Inc. | IBRX | Simon Barry J. Director |
15,243 | $0 | 3,274,059 (Direct) |
View |
| 2025-02-10 Option Award |
2025-02-12 8:17 pm |
N/A N/A |
ImmunityBio Inc. | IBRX | SOON-SHIONG PATRICK See remarks 10% Owner |
3,634,868 | $0 | 3,634,868 (Direct) |
View |
| 2025-02-10 Option Award |
2025-02-12 8:16 pm |
N/A N/A |
ImmunityBio Inc. | IBRX | LAUER REGAN J Chief Accounting Officer |
72,697 | $0 | 72,697 (Direct) |
View |
| 2025-02-10 Option Award |
2025-02-12 8:16 pm |
N/A N/A |
ImmunityBio Inc. | IBRX | Sachs David C. Chief Financial Officer |
1,090,460 | $0 | 1,090,460 (Direct) |
View |
| 2025-02-10 Option Award |
2025-02-12 8:16 pm |
N/A N/A |
ImmunityBio Inc. | IBRX | Adcock Richard CEO & President |
3,634,868 | $0 | 3,634,868 (Direct) |
View |
| 2025-01-22 Exercise |
2025-01-24 8:47 pm |
N/A N/A |
ImmunityBio Inc. | IBRX | Simon Barry J. Director |
110,020 | $1.9984 | 3,233,781 (Direct) |
View |
| 2025-01-22 Exercise |
2025-01-24 8:47 pm |
N/A 2025-02-16 |
ImmunityBio Inc. | IBRX | Simon Barry J. Director |
110,020 | $0 | 3,233,781 (Direct) |
View |
| 2024-12-31 Exercise |
2025-01-03 4:54 pm |
N/A N/A |
ImmunityBio Inc. | IBRX | Adcock Richard CEO & President |
34,483 | $0 | 346,360 (Direct) |
View |
| 2024-12-31 Tax Withholding |
2025-01-03 4:54 pm |
N/A N/A |
ImmunityBio Inc. | IBRX | Adcock Richard CEO & President |
17,475 | $2.56 | 346,360 (Direct) |
View |
| 2024-12-31 Exercise |
2025-01-03 4:54 pm |
N/A N/A |
ImmunityBio Inc. | IBRX | Sachs David C. Chief Financial Officer |
30,397 | $0 | 276,829 (Direct) |
View |
| 2024-12-31 Tax Withholding |
2025-01-03 4:54 pm |
N/A N/A |
ImmunityBio Inc. | IBRX | Sachs David C. Chief Financial Officer |
15,405 | $2.56 | 276,829 (Direct) |
View |
| 2024-12-15 Tax Withholding |
2024-12-16 7:36 pm |
N/A N/A |
ImmunityBio Inc. | IBRX | LAUER REGAN J Chief Accounting Officer |
7,503 | $2.87 | 107,862 (Direct) |
View |
| 2024-12-15 Exercise |
2024-12-16 7:36 pm |
N/A N/A |
ImmunityBio Inc. | IBRX | LAUER REGAN J Chief Accounting Officer |
21,031 | $0 | 107,862 (Direct) |
View |
| 2024-12-10 Conversion |
2024-12-12 9:20 pm |
N/A 2026-09-11 |
ImmunityBio Inc. | IBRX | SOON-SHIONG PATRICK CALIFORNIA CAPITAL EQUITY LLC MP 13 Ventures LLC Cambridge Equities LP Nant Capital LLC See remarks 10% Owner |
230,000,000 | $0 | 1,154,721,761 (Indirect) |
View |
| 2024-12-10 Other |
2024-12-12 9:20 pm |
2024-12-10 2027-12-31 |
ImmunityBio Inc. | IBRX | SOON-SHIONG PATRICK CALIFORNIA CAPITAL EQUITY LLC MP 13 Ventures LLC Cambridge Equities LP Nant Capital LLC See remarks 10% Owner |
505,000,000 | $505,000,000 | 1,154,721,761 (Indirect) |
View |
| 2024-12-10 Other |
2024-12-12 9:20 pm |
2023-12-29 2025-12-31 |
ImmunityBio Inc. | IBRX | SOON-SHIONG PATRICK CALIFORNIA CAPITAL EQUITY LLC MP 13 Ventures LLC Cambridge Equities LP Nant Capital LLC See remarks 10% Owner |
380,000,000 | $0 | 1,154,721,761 (Indirect) |
View |
| 2024-12-10 Conversion |
2024-12-12 9:20 pm |
N/A N/A |
ImmunityBio Inc. | IBRX | SOON-SHIONG PATRICK CALIFORNIA CAPITAL EQUITY LLC MP 13 Ventures LLC Cambridge Equities LP Nant Capital LLC See remarks 10% Owner |
13,475,172 | $2.28 | 1,154,721,761 (Indirect) |
View |
| 2024-12-10 Conversion |
2024-12-12 9:20 pm |
N/A N/A |
ImmunityBio Inc. | IBRX | SOON-SHIONG PATRICK CALIFORNIA CAPITAL EQUITY LLC MP 13 Ventures LLC Cambridge Equities LP Nant Capital LLC See remarks 10% Owner |
103,710,088 | $1.935 | 1,154,721,761 (Indirect) |
View |
| 2024-06-11 Option Award |
2024-06-13 6:50 pm |
N/A 2034-06-11 |
ImmunityBio Inc. | IBRX | Brennan John Owen Director |
77,633 | $0 | 77,633 (Direct) |
View |
| 2024-06-11 Option Award |
2024-06-13 6:49 pm |
N/A 2034-06-11 |
ImmunityBio Inc. | IBRX | Clark Wesley Director |
77,633 | $0 | 77,633 (Direct) |
View |
| 2024-06-11 Option Award |
2024-06-13 6:49 pm |
N/A 2034-06-11 |
ImmunityBio Inc. | IBRX | Cohen Cheryl Director |
77,633 | $0 | 77,633 (Direct) |
View |
| 2024-06-11 Option Award |
2024-06-13 6:49 pm |
N/A 2034-06-11 |
ImmunityBio Inc. | IBRX | Selecky Christobel Director |
77,633 | $0 | 77,633 (Direct) |
View |
| 2024-06-11 Option Award |
2024-06-13 6:49 pm |
N/A 2034-06-11 |
ImmunityBio Inc. | IBRX | BLASZYK MICHAEL D Director |
77,633 | $0 | 77,633 (Direct) |
View |
| 2024-06-11 Option Award |
2024-06-13 6:49 pm |
N/A 2034-06-11 |
ImmunityBio Inc. | IBRX | MAXWELL LINDA Director |
77,633 | $0 | 77,633 (Direct) |
View |
| 2024-02-22 Option Award |
2024-02-26 4:43 pm |
N/A N/A |
ImmunityBio Inc. | IBRX | Simon Barry J. Director |
204,877 | $0 | 204,877 (Direct) |
View |
| 2024-02-22 Option Award |
2024-02-26 4:41 pm |
N/A N/A |
ImmunityBio Inc. | IBRX | LAUER REGAN J Chief Accounting Officer |
54,634 | $0 | 54,634 (Direct) |
View |
| 2024-02-22 Option Award |
2024-02-26 4:40 pm |
N/A N/A |
ImmunityBio Inc. | IBRX | Sachs David C. Chief Financial Officer |
546,341 | $0 | 546,341 (Direct) |
View |
| 2024-02-22 Option Award |
2024-02-26 4:38 pm |
N/A N/A |
ImmunityBio Inc. | IBRX | Adcock Richard CEO & President |
2,048,780 | $0 | 2,048,780 (Direct) |
View |
| 2024-02-22 Option Award |
2024-02-26 4:36 pm |
N/A N/A |
ImmunityBio Inc. | IBRX | SOON-SHIONG PATRICK See remarks 10% Owner |
1,536,584 | $0 | 1,536,584 (Direct) |
View |
| 2024-02-05 Exercise |
2024-02-06 9:14 pm |
N/A N/A |
ImmunityBio Inc. | IBRX | Adcock Richard CEO & President |
83,334 | $0 | 243,138 (Direct) |
View |
| 2024-02-05 Tax Withholding |
2024-02-06 9:14 pm |
N/A N/A |
ImmunityBio Inc. | IBRX | Adcock Richard CEO & President |
43,165 | $4.04 | 243,138 (Direct) |
View |
| 2024-01-31 Exercise |
2024-02-02 7:38 pm |
N/A N/A |
ImmunityBio Inc. | IBRX | Simon Barry J. Director |
57,200 | $0 | 3,123,761 (Direct) |
View |
| 2024-01-31 Tax Withholding |
2024-02-02 7:38 pm |
N/A N/A |
ImmunityBio Inc. | IBRX | Simon Barry J. Director |
22,094 | $3.36 | 3,123,761 (Direct) |
View |
| 2024-01-31 Exercise |
2024-02-02 7:33 pm |
N/A N/A |
ImmunityBio Inc. | IBRX | Sachs David C. Chief Financial Officer |
70,745 | $0 | 185,838 (Direct) |
View |
| 2024-01-31 Tax Withholding |
2024-02-02 7:33 pm |
N/A N/A |
ImmunityBio Inc. | IBRX | Sachs David C. Chief Financial Officer |
26,835 | $3.36 | 185,838 (Direct) |
View |
| 2024-01-31 Exercise |
2024-02-02 7:32 pm |
N/A N/A |
ImmunityBio Inc. | IBRX | LAUER REGAN J Chief Accounting Officer |
32,872 | $0 | 94,334 (Direct) |
View |
| 2024-01-31 Tax Withholding |
2024-02-02 7:32 pm |
N/A N/A |
ImmunityBio Inc. | IBRX | LAUER REGAN J Chief Accounting Officer |
13,470 | $3.36 | 94,334 (Direct) |
View |
| 2023-12-29 Other |
2024-01-03 9:53 pm |
2023-12-29 2025-12-31 |
ImmunityBio Inc. | IBRX | SOON-SHIONG PATRICK Nant Capital LLC See remarks 10% Owner |
380,000,000 | $380,000,000 | 410,000,000 (Indirect) |
View |
| 2023-12-29 Other |
2024-01-03 9:53 pm |
2023-05-12 2025-12-31 |
ImmunityBio Inc. | IBRX | SOON-SHIONG PATRICK Nant Capital LLC See remarks 10% Owner |
30,000,000 | $30,000,000 | 410,000,000 (Indirect) |
View |
| 2023-12-31 Exercise |
2024-01-03 9:41 pm |
N/A N/A |
ImmunityBio Inc. | IBRX | Sachs David C. Chief Financial Officer |
30,397 | $0 | 248,324 (Direct) |
View |
| 2023-12-31 Tax Withholding |
2024-01-03 9:41 pm |
N/A N/A |
ImmunityBio Inc. | IBRX | Sachs David C. Chief Financial Officer |
10,511 | $5.02 | 248,324 (Direct) |
View |
| 2023-12-31 Exercise |
2024-01-03 9:40 pm |
N/A N/A |
ImmunityBio Inc. | IBRX | Adcock Richard CEO & President |
34,483 | $0 | 323,666 (Direct) |
View |
| 2023-12-31 Tax Withholding |
2024-01-03 9:40 pm |
N/A N/A |
ImmunityBio Inc. | IBRX | Adcock Richard CEO & President |
17,096 | $5.02 | 323,666 (Direct) |
View |
| 2023-12-15 Exercise |
2023-12-19 4:41 pm |
N/A N/A |
ImmunityBio Inc. | IBRX | LAUER REGAN J Chief Accounting Officer |
21,030 | $0 | 95,963 (Direct) |
View |
| 2023-09-11 Other |
2023-09-13 9:07 pm |
2022-08-31 2025-09-30 |
ImmunityBio Inc. | IBRX | SOON-SHIONG PATRICK Cambridge Equities LP MP 13 Ventures LLC CALIFORNIA CAPITAL EQUITY LLC Nant Capital LLC See remarks 10% Owner |
269,986,600 | $0 | 765,043,486 (Indirect) |
View |
| 2023-09-11 Other |
2023-09-13 9:07 pm |
N/A N/A |
ImmunityBio Inc. | IBRX | SOON-SHIONG PATRICK Cambridge Equities LP MP 13 Ventures LLC CALIFORNIA CAPITAL EQUITY LLC Nant Capital LLC See remarks 10% Owner |
209,291,936 | $1.29 | 765,043,486 (Indirect) |
View |
| 2023-09-01 Exercise |
2023-09-06 7:41 pm |
N/A N/A |
ImmunityBio Inc. | IBRX | Sachs David C. Chief Financial Officer |
70,744 | $0 | 192,787 (Direct) |
View |
| 2023-09-01 Exercise |
2023-09-06 7:40 pm |
N/A N/A |
ImmunityBio Inc. | IBRX | LAUER REGAN J Chief Accounting Officer |
32,872 | $0 | 86,774 (Direct) |
View |
| 2023-09-01 Exercise |
2023-09-06 7:39 pm |
N/A N/A |
ImmunityBio Inc. | IBRX | Simon Barry J. Director |
57,199 | $0 | 3,145,855 (Direct) |
View |
| 2023-08-25 Option Award |
2023-08-28 9:01 pm |
N/A N/A |
ImmunityBio Inc. | IBRX | Simon Barry J. Director |
114,399 | $0 | 114,399 (Direct) |
View |
| 2023-08-25 Option Award |
2023-08-28 9:00 pm |
N/A N/A |
ImmunityBio Inc. | IBRX | LAUER REGAN J Chief Accounting Officer |
65,744 | $0 | 65,744 (Direct) |
View |
| 2023-08-25 Option Award |
2023-08-28 8:58 pm |
N/A N/A |
ImmunityBio Inc. | IBRX | Sachs David C. Chief Financial Officer |
141,489 | $0 | 141,489 (Direct) |
View |